- Vice President, Global Scientific and Medical Affairs – Synteract
- Chair of the Paediatric Working Group – EUCROF
- Chair of the Children Medicines Working Party - EFGCP
Dr. Martine Dehlinger-Kremer is Vice President, Pediatric Development at Synteract, a CRO with headquarter in California. She has 30 years of experience in the clinical research industry, including more than 26 years of progressively higher levels of Regulatory and Medical Affairs leadership responsibility.
Dr Dehlinger-Kremer has contributed to the global development of numerous products, including orphan drugs and biosimilars. She has participated in more than 100 New Drug Applications (NDAs) and Marketing Authorization Applications (MAAs) in local and common technical document format, eCTD and NeeS format; in the maintenance of products on the market and in numerous clinical studies across all phases.
Dr. Dehlinger-Kremer has served as Chair of the Paediatric Working Group of EUCROF (the European CRO Federation) since 2008 and has influenced the standards, protocols and number of trials conducted for drugs being administered to children. Dr. Dehlinger-Kremer is now EUCROF President. Dr. Dehlinger-Kremer is chair of the EFGCP (European Forum for GCP) Children Medicines Working Party. Dr. Dehlinger-Kremer is also Member of Working Parties of Enpr-EMA, the European Network of Paediatric Research at the European Medicines Agency.
Dr Dehlinger-Kremer was Named One of PharmaVOICE 100’s Most Inspiring People in Life Sciences (Industry leader recognized for impact, experience and advocacy in clinical research) in August 2015.
Dr. Dehlinger-Kremer holds a doctorate in sciences from the University of J.W. Goethe in Frankfurt, a general academic studies degree in neurophysiology from the Louis Pasteur University in Strasbourg, France, and a Master of Science from the University Moulin de la House in Reims, France.